Skip to main content

Table 2 Comparison of laboratory data and the ratios with 3-month mRS and mortality

From: Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke

 

Three-month mRS

Three-month mortality

r

P-value*

Dead

(mean ± SD)

Survived

(mean ± SD)

P-value**

AST(U/I)

0.307

< 0.001

40.85 ± 44.34

24.16 ± 11.18

< 0.001

ALT(U/I)

0.117

0.059

35.64 ± 91.70

21.13 ± 15.90

0.016

ALP(U/I)

0.177

0.004

238.70 ± 126.735

201.96 ± 64.67

0.026

AST/ALT

0.222

< 0.001

1.53 ± 0.56

1.30 ± 0.47

< 0.001

ALP/ALT

−0.002

0.970

11.28 ± 6.00

12.20 ± 7.04

0.262

AST/ALP

0.164

0.008

0.20 ± 0.22

0.13 ± 0.06

< 0.001

  1. AST aspartate transaminase, ALT alanine transaminase, ALP alkaline phosphatase, r Spearman correlation coefficient
  2. *Spearman test
  3. **Mann-Whitney U test, P-value < 0.05 is statistically significant
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us